Responses of myocardial ischemia to escitalopram treatment (REMIT trial)
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Escitalopram (Primary)
- Indications Depressive disorders
- Focus Pharmacodynamics
- Acronyms REMIT
- 31 Aug 2018 Biomarkers information updated
- 04 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 01 Apr 2015 Results published in the American Heart Journal.